Category Archives: Drug and Pharmaceutical Law

Subscribe to Drug and Pharmaceutical Law RSS Feed

Congress Continues to Focus on Prescription Drug Pricing

By Christine Clements and Susan Ingargiola on December 27, 2019 Posted in Drug and Pharmaceutical Law, Healthcare Industry News

The House and Senate continue to focus on prescription drug pricing though it is unclear whether any of the proposals currently pending in either chamber will become law. On December 6th, Senators Grassley and Wyden introduced an updated version of the bipartisan Prescription Drug Pricing Reduction Act (the “PDPRA”). Senate leadership, however, appears to be … Continue Reading

Compliance Risk Alert: Opioid Warning Letters issued by the U.S. Department of Justice Target Prescribers

By Erica Kraus, Michael Paddock, David Douglass, Danielle Vrabie and A. Joseph Jay III on February 6, 2019 Posted in DOJ, Drug and Pharmaceutical Law, Government Investigations

U.S. Attorney’s Offices (“USAOs”) across the country are issuing warning letters to physicians and other prescribers (collectively, “Prescribers”) cautioning them about their opioid prescribing practices (the “Warning Letters”). In just the last week, the USAO for the Eastern District of Wisconsin sent warning letters to over 180 prescribers identified by Drug Enforcement Administration (“DEA”) data … Continue Reading

By scrolling this page, clicking a link or continuing to browse our website, you consent to our use of cookies as described in our Cookie and Advertising Policy. If you do not wish to accept cookies from our website, or would like to stop cookies being stored on your device in the future, you can find out more and adjust your preferences here.

Agree